These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28301446)

  • 1. Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign - Angola, 2016.
    Boyd AT; Dombaxe D; Moreira R; Oliveira MS; Manuel E; Colorado CN; Lanzieri TM
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(10):282-283. PubMed ID: 28301446
    [No Abstract]   [Full Text] [Related]  

  • 2. Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak - Luanda, Angola, 2016.
    Marlow MA; Pambasange MA; Francisco C; Receado OD; Soares MJ; Silva S; Navarro-Colorado C; Zielinski-Gutierrez E
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(4):117-118. PubMed ID: 28151922
    [No Abstract]   [Full Text] [Related]  

  • 3. Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand.
    Barrett AD
    N Engl J Med; 2016 Jul; 375(4):301-3. PubMed ID: 27276108
    [No Abstract]   [Full Text] [Related]  

  • 4. Another pandemic disaster looms: yellow fever spreading from Angola.
    Woodall JP
    Pan Afr Med J; 2016; 24():107. PubMed ID: 27642446
    [No Abstract]   [Full Text] [Related]  

  • 5. INFECTIOUS DISEASES. Yellow fever outbreak triggers vaccine alarm.
    Kupferschmidt K
    Science; 2016 Apr; 352(6282):128-9. PubMed ID: 27124428
    [No Abstract]   [Full Text] [Related]  

  • 6. Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China.
    Song R; Guan S; Lee SS; Chen Z; Chen C; Han L; Xu Y; Li A; Zeng H; Ye H; Zhang F
    Emerg Infect Dis; 2018 Jul; 24(7):1383-6. PubMed ID: 29723485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.
    Casey RM; Harris JB; Ahuka-Mundeke S; Dixon MG; Kizito GM; Nsele PM; Umutesi G; Laven J; Kosoy O; Paluku G; Gueye AS; Hyde TB; Ewetola R; Sheria GKM; Muyembe-Tamfum JJ; Staples JE
    N Engl J Med; 2019 Aug; 381(5):444-454. PubMed ID: 29443626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccination coverage heterogeneities in Luanda province, Angola.
    Majumder MS; Nguyen CM; Mekaru SR; Brownstein JS
    Lancet Infect Dis; 2016 Sep; 16(9):993-995. PubMed ID: 27684332
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow fever urban outbreak in Angola and the risk of extension.
    Wkly Epidemiol Rec; 2016 Apr; 91(14):186-92. PubMed ID: 27066610
    [No Abstract]   [Full Text] [Related]  

  • 11. Suspected YF-AND after yellow fever vaccination in Finland.
    Jääskeläinen AJ; Huhtamo E; Kivioja R; Domingo C; Vene S; Kallio-Kokko H; Niedrig M; Tienari PJ; Vapalahti O
    J Clin Virol; 2014 Nov; 61(3):444-7. PubMed ID: 25223921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study.
    Doshi RH; Mukadi PK; Casey RM; Kizito GM; Gao H; Nguete U B; Laven J; Sabi L; Kaba DK; Muyembe-Tamfum JJ; Hyde TB; Ahuka-Mundeke S; Staples JE
    Lancet Infect Dis; 2024 Jun; 24(6):611-618. PubMed ID: 38335976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever vaccination - Once in a lifetime?
    Grobusch MP; van Aalst M; Goorhuis A
    Travel Med Infect Dis; 2017; 15():1-2. PubMed ID: 28013052
    [No Abstract]   [Full Text] [Related]  

  • 16. Yellow fever: a global reckoning.
    The Lancet
    Lancet; 2016 Apr; 387(10026):1348. PubMed ID: 27115797
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast.
    Fitzner J; Coulibaly D; Kouadio DE; Yavo JC; Loukou YG; Koudou PO; Coulombier D
    Vaccine; 2004 Nov; 23(2):156-62. PubMed ID: 15531032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the large-scale yellow fever outbreak in Luanda, Angola, and the impact of vaccination.
    Zhao S; Stone L; Gao D; He D
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006158. PubMed ID: 29338001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resurgence of Yellow Fever in Angola, 2015-2016.
    Grobbelaar AA; Weyer J; Moolla N; Jansen van Vuren P; Moises F; Paweska JT
    Emerg Infect Dis; 2016 Oct; 22(10):1854-5. PubMed ID: 27536787
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
    Suzano CE; Amaral E; Sato HK; Papaiordanou PM;
    Vaccine; 2006 Feb; 24(9):1421-6. PubMed ID: 16236402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.